Moitra R - Search Results

1

Antagonism of the Neurokinin-1 Receptor Improves Survival in a Mouse Model of Sepsis by Decreasing Inflammation and Increasing Early Cardiovascular Function.

Mella JR, Chiswick E, Stepien D, Moitra R, Duffy ER, Stucchi A, Remick D. Mella JR, et al. Among authors: moitra r. Crit Care Med. 2017 Feb;45(2):e213-e221. doi: 10.1097/CCM.0000000000002075. Crit Care Med. 2017. PMID: 27632670 Free PMC article.

2

Cecal ligation and puncture-induced murine sepsis does not cause lung injury.

Iskander KN, Craciun FL, Stepien DM, Duffy ER, Kim J, Moitra R, Vaickus LJ, Osuchowski MF, Remick DG. Iskander KN, et al. Among authors: moitra r. Crit Care Med. 2013 Jan;41(1):159-70. doi: 10.1097/CCM.0b013e3182676322. Crit Care Med. 2013. PMID: 23222255 Free PMC article.

3

Presence of preexisting antibodies mediates survival in sepsis.

Moitra R, Beal DR, Belikoff BG, Remick DG. Moitra R, et al. Shock. 2012 Jan;37(1):56-62. doi: 10.1097/SHK.0b013e3182356f3e. Shock. 2012. PMID: 21921828 Free PMC article.

4

Adenosine receptor antagonists effect on plasma-enhanced killing.

Bauzá G, Moitra R, Remick D. Bauzá G, et al. Among authors: moitra r. Shock. 2014 Jan;41(1):62-6. doi: 10.1097/SHK.0000000000000055. Shock. 2014. PMID: 24089004 Free PMC article.

5

Impact of natural IgM concentration on gene therapy with adenovirus type 5 vectors.

Qiu Q, Xu Z, Tian J, Moitra R, Gunti S, Notkins AL, Byrnes AP. Qiu Q, et al. Among authors: moitra r. J Virol. 2015 Mar;89(6):3412-6. doi: 10.1128/JVI.03217-14. Epub 2014 Dec 31. J Virol. 2015. PMID: 25552715 Free PMC article.

6

Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum.

Harmon AW, Moitra R, Xu Z, Byrnes AP. Harmon AW, et al. Among authors: moitra r. PLoS One. 2018 Feb 5;13(2):e0192353. doi: 10.1371/journal.pone.0192353. eCollection 2018. PLoS One. 2018. PMID: 29401488 Free PMC article.

7

Binding of adenovirus species C hexon to prothrombin and the influence of hexon on vector properties in vitro and in vivo.

Tian J, Xu Z, Moitra R, Palmer DJ, Ng P, Byrnes AP. Tian J, et al. Among authors: moitra r. PLoS Pathog. 2022 Sep 26;18(9):e1010859. doi: 10.1371/journal.ppat.1010859. eCollection 2022 Sep. PLoS Pathog. 2022. PMID: 36156097 Free PMC article.

8

Socioeconomic deprivation is associated with reduced response and lower treatment persistence with TNF inhibitors in rheumatoid arthritis.

Zhao SS, Rogers K, Kearsley-Fleet L, Watson K, Bosworth A, Galloway J, Verstappen S, Plant D; BSRBR-RA Contributors Group, BRAGGSS Collaborators; Barton A, Hyrich KL, Humphreys JH. Zhao SS, et al. Rheumatology (Oxford). 2024 Mar 1;63(3):648-656. doi: 10.1093/rheumatology/kead261. Rheumatology (Oxford). 2024. PMID: 37267152 Free PMC article.

9

Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis.

Hum RM, Ho P, Nair N, Jani M, Morgan AW, Isaacs JD, Wilson AG, Hyrich KL, Plant D, Barton A; BRAGGSS Collaborators. Hum RM, et al. Rheumatology (Oxford). 2023 Jun 1;62(6):2090-2097. doi: 10.1093/rheumatology/keac564. Rheumatology (Oxford). 2023. PMID: 36190343 Free PMC article.

10

Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritis.

Jani M, Chinoy H, Warren RB, Griffiths CE, Plant D, Fu B, Morgan AW, Wilson AG, Isaacs JD, Hyrich K, Barton A; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate Collaborators. Jani M, et al. Arthritis Rheumatol. 2015 May;67(8):2011-9. doi: 10.1002/art.39169. Arthritis Rheumatol. 2015. PMID: 26109489 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page